Janux Therapeutics (JANX) is down -48.4%, or -$16.46 to $17.52.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JANX:
- Janux Therapeutics falls -49.4%
- Optimistic Buy Rating for Janux Therapeutics Despite Challenges and Promising Market Potential
- Janux Therapeutics price target lowered to $150 from $200 at Cantor Fitzgerald
- Janux Therapeutics price target lowered to $38 from $46 at Stifel
- Why Is Janux Therapeutics Stock (JANX) Crashing today?